342 related articles for article (PubMed ID: 38539448)
1. Paracrine Regulation and Immune System Pathways in the Inflammatory Tumor Microenvironment of Lung Cancer: Insights into Oncogenesis and Immunotherapeutic Strategies.
Batrash F; Shaik A; Rauf R; Kutmah M; Zhang J
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539448
[TBL] [Abstract][Full Text] [Related]
2. Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications.
Fang J; Lu Y; Zheng J; Jiang X; Shen H; Shang X; Lu Y; Fu P
Cell Death Dis; 2023 Sep; 14(9):586. PubMed ID: 37666809
[TBL] [Abstract][Full Text] [Related]
3. Single-Cell Profiling Comparisons of Tumor Microenvironment between Primary Advanced Lung Adenocarcinomas and Brain Metastases and Machine Learning Algorithms in Predicting Immunotherapeutic Responses.
Wu Y; Kang K; Han C; Wang L; Wang Z; Zhao A
Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671569
[TBL] [Abstract][Full Text] [Related]
4. Unraveling tumor microenvironment of small-cell lung cancer: Implications for immunotherapy.
Li T; Qiao T
Semin Cancer Biol; 2022 Nov; 86(Pt 2):117-125. PubMed ID: 36183998
[TBL] [Abstract][Full Text] [Related]
5. Deciphering the role of HPV-mediated metabolic regulation in shaping the tumor microenvironment and its implications for immunotherapy in HNSCC.
Gong X; Xiong J; Gong Y; Zhang J; Zhang J; Yang G; Chi H; Tian G
Front Immunol; 2023; 14():1275270. PubMed ID: 37876923
[TBL] [Abstract][Full Text] [Related]
6. Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity.
Chakraborty S; Carnazza M; Jarboe T; DeSouza N; Li XM; Moscatello A; Geliebter J; Tiwari RK
Adv Exp Med Biol; 2021; 1350():33-66. PubMed ID: 34888843
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Review: Unveiling the Pro-Oncogenic Roles of IL-1ß and PD-1/PD-L1 in NSCLC Development and Targeting Their Pathways for Clinical Management.
Castillo DR; Jeon WJ; Park D; Pham B; Yang C; Joung B; Moon JH; Lee J; Chong EG; Park K; Reeves ME; Duerksen-Hughes P; Mirshahidi HR; Mirshahidi S
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511306
[TBL] [Abstract][Full Text] [Related]
8. The Ferroptosis Molecular Subtype Reveals Characteristics of the Tumor Microenvironment, Immunotherapeutic Response, and Prognosis in Gastric Cancer.
Xu X; Zhou N; Lan H; Yang F; Dong B; Zhang X
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077165
[TBL] [Abstract][Full Text] [Related]
9. Implications for Immunotherapy of Breast Cancer by Understanding the Microenvironment of a Solid Tumor.
Franzén AS; Raftery MJ; Pecher G
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804950
[TBL] [Abstract][Full Text] [Related]
10. Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencing.
Xue Q; Peng W; Zhang S; Wei X; Ye L; Wang Z; Xiang X; Zhang P; Zhou Q
Front Immunol; 2023; 14():1148061. PubMed ID: 37187731
[TBL] [Abstract][Full Text] [Related]
11. Tumor microenvironment signaling and therapeutics in cancer progression.
Goenka A; Khan F; Verma B; Sinha P; Dmello CC; Jogalekar MP; Gangadaran P; Ahn BC
Cancer Commun (Lond); 2023 May; 43(5):525-561. PubMed ID: 37005490
[TBL] [Abstract][Full Text] [Related]
12. Tumor Microenvironment and Immunotherapy Response in Head and Neck Cancer.
Economopoulou P; Kotsantis I; Psyrri A
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33203092
[TBL] [Abstract][Full Text] [Related]
13. The Microenvironment of Lung Cancer and Therapeutic Implications.
Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapeutic targets in non-small cell lung cancer.
Sadeghirad H; Bahrami T; Layeghi SM; Yousefi H; Rezaei M; Hosseini-Fard SR; Radfar P; Warkiani ME; O'Byrne K; Kulasinghe A
Immunology; 2023 Feb; 168(2):256-272. PubMed ID: 35933597
[TBL] [Abstract][Full Text] [Related]
15. Unlocking the potential of the tumor microenvironment for cancer therapy.
Tufail M
Pathol Res Pract; 2023 Nov; 251():154846. PubMed ID: 37837860
[TBL] [Abstract][Full Text] [Related]
16. Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies.
Li YR; Fang Y; Lyu Z; Zhu Y; Yang L
J Transl Med; 2023 Oct; 21(1):686. PubMed ID: 37784157
[TBL] [Abstract][Full Text] [Related]
17. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
Zhu Y; Li X; Wang L; Hong X; Yang J
Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
[TBL] [Abstract][Full Text] [Related]
18. Integration of multiple key molecules in lung adenocarcinoma identifies prognostic and immunotherapeutic relevant gene signatures.
Wu Q; Wang L; Wei H; Li B; Yang J; Wang Z; Xu J; Zhou YL; Zhang B
Int Immunopharmacol; 2020 Jun; 83():106477. PubMed ID: 32278127
[TBL] [Abstract][Full Text] [Related]
19. Understanding the regulation of "Don't Eat-Me" signals by inflammatory signaling pathways in the tumor microenvironment for more effective therapy.
Karizak AZ; Salmasi Z; Gheibihayat SM; Asadi M; Ghasemi Y; Tajbakhsh A; Savardashtaki A
J Cancer Res Clin Oncol; 2023 Jan; 149(1):511-529. PubMed ID: 36342520
[TBL] [Abstract][Full Text] [Related]
20. Roles of the CXCL8-CXCR1/2 Axis in the Tumor Microenvironment and Immunotherapy.
Han ZJ; Li YB; Yang LX; Cheng HJ; Liu X; Chen H
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
